copertina Graefe

New evidences on efficacy of Chromo4Vis

The third paper on our breakthrough technology has been recently e-published on Graefes Arch Clin Exp Ophthalmol.  It can downloaded at the researchgate webiste.

Chromo4Vis assists the surgeon to obtain the most effective intended outcome regardless of the procedures used during corneal cross-linking.

Learn about theranostics and the future of image-guided corneal cross-linking for precise therapy of keratoconus and corneal ectasia.

Vision Engineering Italy is innovating eye care with smart solutions!


Vision Engineering Italy at the China-Italy Best Startup Competition

Vision Engineering Italy srl will participate in the semifinal of the China-Italy Best Startup Showcase-Entrepreneurship Competition (BSSEC) in the “Health and Life Sciences” sector.

The BSSEC is a promotion program in the Chinese startup market coordinated by the International Technology Transfer Network and by Città della Scienza.

Giuseppe and Marco Lombardo will present the Chromo4Vis project which is introducing the first theranostic medical device in eye care. Chromo4Vis is a smart device for the personalized treatment of keratoconus, which is the primary cause of corneal transplantation in young people.

The event will be held at the Faculty of Medicine of the University La Sapienza University of Rome in Via Caserta n.6 at 9.30 am on October 11.


foto Marco sala 1

Preclinical results on the innovative image-guided corneal cross-linking for keratoconus

Dr. Marco Lombardo will present the preclinical results on efficacy of Chromo4Vis at the VIII “Segmant” Course on diagnostics and therapy of keratoconus that will be held in Naples on September 27th 2019.

Chromo4Vis is the first medical device for the personalized treatment of keratoconus; it will provide surgeons with image-guided corneal cross-linking to tailor treatment to each patient and to achieve 100% efficacy and safety for all!

The Course will be held at the Monaldi Hospital in Naples from 9.00 am to 4.00 pm on Friday 27th September.